Science Explorer Back to mapMap

Most cited papers from Southeast Renal Research Institute

What are the most cited papers from Southeast Renal Research Institute?

The most cited paper from Southeast Renal Research Institute is "Risk Prediction of Contrast-Induced Nephropathy" (Peter Andrew McCullough, Andy Adam, Christoph R. Becker et al., 2006), with 461 citations. Next come "Epidemiology and Prognostic Implications of Contrast-Induced Nephropathy" (436) and "Pathophysiology of Contrast-Induced Nephropathy" (395).

Showing 24 of 24 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Risk Prediction of Contrast-Induced Nephropathy Peter Andrew McCullough, Andy Adam, Christoph R. Becker et al. · The American Journal of Cardiology 24 Feb 2006 461
2 Epidemiology and Prognostic Implications of Contrast-Induced Nephropathy Peter Andrew McCullough, Andy Adam, Christoph R. Becker et al. · The American Journal of Cardiology 11 Feb 2006 436
3 Pathophysiology of Contrast-Induced Nephropathy James Alan Tumlin, Fulvio Stacul, Andy Adam et al. · The American Journal of Cardiology 20 Feb 2006 395
4 Strategies to Reduce the Risk of Contrast-Induced Nephropathy Fulvio Stacul, Andy Adam, Christoph R. Becker et al. · The American Journal of Cardiology 21 Mar 2006 256
5 Ferric Citrate Controls Phosphorus and Delivers Iron in Patients on Dialysis Julia Breyer Lewis, Mohammed Sika, Mark J. Koury et al. · Journal of the American Society of Nephrology Open access 24 Jul 2014 192
6 Contrast Medium Use Charles J. Davidson, Fulvio Stacul, Peter Andrew McCullough et al. · The American Journal of Cardiology 3 Mar 2006 170
7 Economic burden of contrast-induced nephropathy: implications for prevention strategies Sujha Subramanian, James Alan Tumlin, Bela Bapat et al. · Journal of Medical Economics Open access 2007 148
8 Baseline Renal Function Screening Norbert Hendrik Lameire, Andy Adam, Christoph R. Becker et al. · The American Journal of Cardiology 21 Feb 2006 121
9 Proposal for a Functional Classification System of Heart Failure in Patients With End-Stage Renal Disease Lakhmir S. Chawla, Charles A. Herzog, Maria Rosa Costanzo et al. · Journal of the American College of Cardiology Open access 12 Feb 2014 93
10 Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography Roxana Mehran, Michela Faggioni, Jaya Chandrasekhar et al. · JACC: Cardiovascular Interventions Open access Aug 2018 47
11 Overview Peter Andrew McCullough, Fulvio Stacul, Charles J. Davidson et al. · The American Journal of Cardiology 14 Feb 2006 43
12 High-Risk Situations and Procedures Christoph R. Becker, Charles J. Davidson, Norbert Hendrik Lameire et al. · The American Journal of Cardiology 21 Feb 2006 40
13 Soluble urokinase receptor and focal segmental glomerulosclerosis Jochen Reiser, Changli Wei, James Alan Tumlin · Current Opinion in Nephrology & Hypertension 8 May 2012 36
14 A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Tenecteplase for Improvement of Hemodialysis Catheter Function James Alan Tumlin, Jesse M. Goldman, David M. Spiegel et al. · Clinical Journal of the American Society of Nephrology Open access 4 Feb 2010 32
15 Phase IIa Study of the Immunogenicity and Safety of the Novel Staphylococcus aureus Vaccine V710 in Adults with End-Stage Renal Disease Receiving Hemodialysis Moustafa Sherief Moustafa, George R. Aronoff, Chandra B. Chandran et al. · Clinical and Vaccine Immunology Open access 26 Jul 2012 30
16 Oral Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG‐4592) for Treatment of Anemia in Chronic Kidney Disease: A Placebo‐Controlled Study of Pharmacokinetic and Pharmacodynamic Profiles in Hemodialysis Patients Robert Provenzano, James Alan Tumlin, Raja I. Zabaneh et al. · The Journal of Clinical Pharmacology Open access 30 Jun 2020 29
17 Advanced Diabetic Nephropathy with Nephrotic Range Proteinuria: A Pilot Study of the Long-Term Efficacy of Subcutaneous ACTH Gel on Proteinuria, Progression of CKD, and Urinary Levels of VEGF and MCP-1 James Alan Tumlin, Claude M. Galphin, Brad H. Rovin · Journal of Diabetes Research Open access 2013 25
18 Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial Javier A Neyra et al. · The Lancet Respiratory Medicine Open access 23 Mar 2026 20
19 Impaired blood flow in acute kidney injury: pathophysiology and potential efficacy of intrarenal vasodilator therapy James Alan Tumlin · Current Opinion in Critical Care 7 Nov 2009 20
20 Bayesian methods: a potential path forward for sepsis trials GEORGE A. TOMLINSON, Ali H. Al-Khafaji, Steven A. Conrad et al. · Critical Care Open access 8 Nov 2023 19
21 Organ Failure, Endotoxin Activity, and Mortality in Septic Shock Luca Molinari, Mark Tidswell, Ali H. Al-Khafaji et al. · Critical Care Explorations Open access 28 Aug 2025 3
22 254 Pharmacokinetics of Oral FG-4592 to Treat Anemia in Hemodialysis (HD) Patients (PTS) Robert Provenzano, James Alan Tumlin, Raja I. Zabaneh et al. · American Journal of Kidney Diseases Apr 2011 2
23 3: COMBINATION OF ENDOTOXIN ACTIVITY AND SOFA DEFINES SEVERITY IN SEPTIC SHOCK Mark Tidswell, Ali H. Al-Khafaji, Danielle L Davison et al. · Critical Care Medicine 2025 1
24 227 James Alan Tumlin, Claude M. Galphin, Mandeep Singh Grewal · American Journal of Kidney Diseases Apr 2007 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.